Organogenesis Holdings Inc. (ORGO)

Organogenesis Holdings Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	46.1	93.68	135.57	103.84	102.48	113.93
Short-Term Investments	-	2.24	0.31	0.87	-	-
Cash & Short-Term Investments	46.1	95.92	135.88	104.71	102.48	113.93
Cash Growth	-36.92%	-29.41%	29.77%	2.18%	-10.05%	35.00%
Receivables	100.94	217.45	109.86	82	89.45	82.46
Inventory	29.28	29.63	26.22	28.25	24.78	25.02
Prepaid Expenses	19.63	13	13.02	9.26	4.37	3.64
Restricted Cash	0.75	0.65	0.58	0.5	0.81	0.6
Other Current Assets	3.61	5.53	0.38	0.32	0.72	1.33
Total Current Assets	200.3	362.19	285.94	225.04	222.61	226.98
Property, Plant & Equipment	151.44	159.46	126.24	156.35	145.66	128.3
Goodwill	28.77	28.77	28.77	28.77	28.77	28.77
Other Intangible Assets	3	9.15	12.47	15.87	20.79	25.67
Long-Term Deferred Tax Assets	-	29.96	39.46	28	30.01	31.99
Long-Term Deferred Charges	-	-	-	-	-	1.22
Other Long-Term Assets	22.93	9.2	5.01	5.99	1.52	0.31
Total Assets	406.45	598.73	497.89	460.03	449.36	443.26

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	29.29	31.95	28.91	30.72	32.33	29.34
Accrued Expenses	18.36	44.41	31.22	21.36	20.43	30.32
Current Portion of Long-Term Debt	-	-	-	5.49	4.54	2.66
Current Portion of Leases	9.31	18.64	9.11	16.55	14.17	15.95
Current Income Taxes Payable	-	-	4.29	2.8	2.63	1.16
Current Unearned Revenue	-	3.86	-	-	-	-
Other Current Liabilities	-	1.26	3.95	3.59	0.93	3.28
Total Current Liabilities	56.96	100.12	77.48	80.51	75.02	82.71
Long-Term Debt	-	-	-	60.75	66.23	70.77
Long-Term Leases	57.64	63.5	34.2	38.9	41.31	46.89
Other Long-Term Liabilities	3.71	1.19	0.89	1.21	1.12	1.56
Total Liabilities	118.31	164.81	112.57	181.36	183.69	201.92

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	300.76	303.19	302.99	319.62	310.96	302.16
Retained Earnings	-152.5	-3.08	-40.11	-40.97	-45.3	-60.83
Total Common Equity	148.27	300.13	262.9	278.66	265.67	241.34
Shareholders' Equity	288.13	433.92	385.32	278.66	265.67	241.34
Total Liabilities & Equity	406.45	598.73	497.89	460.03	449.36	443.26

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	66.95	82.14	43.31	121.68	126.25	136.27
Net Cash (Debt)	-20.85	13.79	92.57	-16.97	-23.78	-22.34
Net Cash Growth	-	-85.11%	-	-	-	-
Net Cash Per Share	-0.16	0.11	0.70	-0.13	-0.18	-0.17
Filing Date Shares Outstanding	128.67	128.64	126.83	131.96	131.18	128.77
Total Common Shares Outstanding	128.67	126.95	125.73	131.32	130.92	128.68
Working Capital	143.34	262.06	208.46	144.54	147.59	144.27
Book Value Per Share	1.15	2.36	2.09	2.12	2.03	1.88
Tangible Book Value	116.49	262.21	221.66	234.02	216.11	186.89
Tangible Book Value Per Share	0.91	2.07	1.76	1.78	1.65	1.45
Buildings	-	-	13.6	4.94	4.94	4.94
Machinery	-	69.23	63.25	64.59	57.15	53.96
Construction In Progress	-	26.74	21.89	59.07	65.56	47.46
Leasehold Improvements	-	67.87	63.34	60.82	37.61	30.53

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: May 7, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 2, 2026

Data Sources Report a data error